Microneedling

Dr. Sarah Chen
PhD, Molecular Biology
Microneedling β also called percutaneous collagen induction therapy (PCIT) or collagen induction therapy (CIT) β is a minimally invasive dermatological procedure that uses fine needles to create thousands of controlled micro-puncture wounds in the skin [1,2].
Definition
Microneedling β also called percutaneous collagen induction therapy (PCIT) or collagen induction therapy (CIT) β is a minimally invasive dermatological procedure that uses fine needles to create thousands of controlled micro-puncture wounds in the skin [1][2]. These micro-injuries trigger the body's wound healing cascade, stimulating fibroblast activation, new collagen synthesis, and extracellular matrix remodeling without the thermal damage or significant downtime associated with ablative laser procedures [1].
Mechanism of Action
The Wound Healing Cascade
Microneedling's therapeutic effect relies on the three overlapping phases of wound healing [1][2]:
Phase 1 β Inflammation (0β48 hours): Needle punctures breach the epidermis and penetrate into the dermis, triggering platelet degranulation and release of growth factors including PDGF, TGF-alpha, TGF-beta, and FGF. Neutrophils and macrophages migrate to the wound sites to clear debris and release additional cytokines that recruit fibroblasts [1].
Phase 2 β Proliferation (2β14 days): Fibroblasts migrate to the micro-wound sites and begin synthesizing new collagen (primarily type III), elastin, glycosaminoglycans, and other extracellular matrix components. Angiogenesis supplies the new tissue with blood vessels. Keratinocytes proliferate to resurface the micro-channels [1][2].
Phase 3 β Remodeling (14 daysβ12 months): Type III collagen is gradually replaced by stronger type I collagen. The newly deposited matrix cross-links and matures, progressively improving skin firmness, texture, and appearance over months [2].
Needle Depth and Indications
The depth of needle penetration determines the treatment target [1][2]:
- 0.25β0.5mm β Enhances topical product absorption without significant collagen induction. Used for at-home dermarolling and product delivery.
- 0.5β1.0mm β Reaches the papillary dermis. Effective for fine lines, superficial pigmentation, and mild acne scars.
- 1.0β1.5mm β Reaches the reticular dermis. Used for moderate wrinkles, acne scars, and stretch marks.
- 1.5β2.5mm β Deep dermal penetration for severe acne scars, deep wrinkles, and significant skin laxity. Professional-only depth.
PDRN and Microneedling
The combination of PDRN with microneedling is one of the most synergistic treatment protocols in regenerative dermatology [3][4]:
Enhanced Delivery
Microneedling creates thousands of micro-channels through the stratum corneum β the skin's primary barrier to topical ingredient penetration. When PDRN is applied during or immediately after microneedling, these channels allow the polynucleotide fragments to bypass the epidermal barrier and reach the dermal fibroblasts directly [3]. Studies have shown that microneedling can increase transdermal absorption of topical agents by 80% or more compared to intact skin application [1].
Amplified Wound Healing Response
Microneedling creates the controlled injury; PDRN amplifies the repair response. The micro-wounds activate the body's natural wound healing cascade, while PDRN simultaneously activates adenosine A2A receptors on the recruited fibroblasts, accelerating their proliferative and biosynthetic activity beyond what the wound stimulus alone would produce [3][5]. The result is more collagen deposition, faster tissue remodeling, and superior clinical outcomes compared to microneedling alone.
Reduced Downtime
PDRN's anti-inflammatory properties β suppression of TNF-alpha, IL-6, and other pro-inflammatory cytokines β help modulate the inflammatory phase of post-microneedling wound healing [3]. This reduces post-procedural redness, swelling, and discomfort without compromising the regenerative response, effectively shortening the visible recovery period.
Superior Collagen Quality
PDRN's sustained fibroblast activation promotes the synthesis of organized, physiological collagen rather than the disorganized scar-like collagen that can result from excessive or unmodulated wound healing [4][5]. By supporting normal extracellular matrix assembly, PDRN helps ensure that the new collagen produced after microneedling integrates properly into the existing dermal architecture.
Clinical Applications
Acne Scars
Microneedling with PDRN is one of the most effective non-surgical treatments for atrophic acne scars [2][4]. The needles break up fibrous scar tissue bands while PDRN stimulates new collagen deposition to fill depressed scars from below.
Skin Rejuvenation
For general anti-aging, microneedling with PDRN produces measurable improvements in skin elasticity, firmness, hydration, and fine line reduction after a series of 3β6 monthly sessions [4].
Stretch Marks
Deep microneedling (1.5β2.0mm) combined with PDRN can improve the appearance of striae by stimulating collagen and elastin production in the atrophic dermal tissue characteristic of stretch marks [2].
Post-Microneedling PDRN Protocol
A typical professional protocol [3][4]:
- During procedure β Apply PDRN solution to the skin during microneedling, allowing it to enter micro-channels as they are created
- Immediately after β Apply additional PDRN serum to maximize delivery through open channels
- Days 1β3 β Apply topical PDRN serum twice daily to support the proliferative phase
- Days 4β14 β Continue twice-daily PDRN serum application during the remodeling phase
- Weeks 3β4 β Maintain PDRN use through the collagen maturation phase until the next session
References
- [1]Fernandes D. Minimally invasive percutaneous collagen induction. Oral Maxillofac Surg Clin North Am. 2005;17(1):51-63. doi:10.1016/j.coms.2004.09.004
- [2]Aust MC, Fernandes D, Kolokber P, Knobloch K, Vogt PM. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles, and skin laxity. Plast Reconstr Surg. 2008;121(4):1421-1429. doi:10.1097/01.prs.0000304612.72899.f0
- [3]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [4]Kim TH, Kim JY, Bae JH, et al.. Biostimulatory effects of polydeoxyribonucleotide for facial skin rejuvenation. J Cosmet Dermatol. 2019;18(6):1767-1773. doi:10.1111/jocd.12958
- [5]Galeano M, Bitto A, Altavilla D, et al.. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x